On behalf of the USC/CHLA Cell Therapy Program:

"Towards the Development of Synthetic Immunity to Cancer" 

Part of the USC/CHLA Cell Therapy Program Seminar Series

Thursday, March 2, 2023

12:00-1:00pm

​Learn more about:

• Advanced synthetic receptor systems to customize immune cell therapies, improving their safety and efficacy
• High-throughput approaches to receptor and signaling circuit design for T cell therapeutics
•  New T cell enhancement strategies to counteract immunosuppression in solid tumors 

Speaker:

Kole T. Roybal, Ph.D 

Associate Professor | Microbiology & Immunology 

University of California, San Francisco 

Parker Institute for Cancer Immunotherapy 

Chan Zuckerberg Biohub Investigator 

Helen Diller Family Comprehensive Cancer Center 

Register today via:

https://usc.zoom.us/meeting/register/tJAod-urqzgpHdXlRLYgTfQf3V-Jr5DLkrG-